The high frequency of these two combinations is unsurprising given that CDKN2A/2BDEL is the most recurrently reported CNA in B-ALL, and frequently, the deletion also removes PAX5, which is located close to the CDKN2A/2B complex. This evidence concerns the gene CDKN2A and precursor B-cell acute lymphoblastic leukemia.